Navigation Links
Successful Results for Mymetics Corporation's Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
Date:9/16/2008

NYON, Switzerland, September 16 /PRNewswire-FirstCall/ -- Mymetics Corporation (OTCBB: MYMX), a vaccine development company, is pleased to announce their preliminary SHIV challenge results on non-human primates previously immunized with the Company's mucosal HIV-AIDS vaccine designed for triggering mucosal protection. The results significantly exceed the Industry standard of 60% to 70% effectiveness to be considered as a promising vaccine as well as of Mymetics' expectation which was considerable above this level. The Company will continue to do further tests to confirm these results and will present the all results at the Keystone Symposia. With the recent public announcements by major HIV opinion leaders and pharmaceutical companies of their disappointing results despite significant investments in non productive vaccine strategies, attention is now beginning to refocus on the mucosa approach. Mymetics, with a robust IP portfolio and having originally decided 5 years ago to develop an HIV vaccine utilising mucosal antibody protection as the first line of defence, anticipates a fundamental change in the direction of HIV/AIDS research towards the mucosa solution in the near future.

Mymetics' viral challenge was its second non-human primate study conducted by the Institute of Laboratory Animal Science & Chinese Academy of Medical Science (ILAS) in Beijing. ILAS, a globally recognized analytical facility, have and continue to be used by leading US scientists and major governmental entities for ongoing scientific testing. This study used macaques for evaluating Mymetics' latest HIV vaccine formulation and consisted of three differing methodologies of immunizing the macaques. The macaques were intra-vaginally challenged thirteen times with the chimeric SHIV. Female Chinese Macaca Mulata (macaques) were chosen as their infection by SHIV through the genital route closely resembles the observed human infection rate by HIV. The company expects to present the fu
'/>"/>

SOURCE Mymetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
3. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
4. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407
8. Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
11. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Pa. , July 10, 2014 ... Moberg Research,s (Moberg) medical device manufacturing facility. Rep. ... Moberg,s advanced neurological monitors facilitate cutting-edge research in ... Rep. Kennedy and mental health advocate, Garen ... organization dedicated to fostering fundamental changes that will ...
(Date:7/10/2014)... LAVAL, Quebec , July 10, 2014  Valeant ... TSX: VRX) today announced it has completed the sale ... Sculptra, and Dysport owned or held by Valeant for ... agreement with Nestle S.A, which recently completed its acquisition ... complete the divestiture of our products to a company ...
(Date:7/10/2014)... July 10, 2014  Decision Resources Group finds ... disease (ID) specialists are willing to prescribe Durata,s ... for use as OPAT, approximately two-thirds of the ... to their hospital inpatients. However, our findings indicate ... are initiated on OPAT following hospital discharge, and ...
Breaking Medicine Technology:Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... 2011 An Illinois high school hockey coach is ... Tim Johannes, who coaches at Stevenson High ... anyone wearing helmets with the risk of sustaining a ... The Shockwave System is a three-step system, ...
... Pharmaceutical, Inc., a leading national wholesale distributor of pharmaceutical ... A. Corona to president and COO. Corona, ... Masters in 2002 and under his tenure has helped ... "Wayne has contributed greatly to our growth, ...
Cached Medicine Technology:Shockwave System Developed to Aid Concussion Detection 2
(Date:7/13/2014)... July 13, 2014 If Dr. Lawrence Power ... has just launched at http://www.HealthYourself101.com will expand people’s ... , Power has set out to provide a health ... that’s actually – dare we say it? – entertaining to ... Power, “aims to engage the remote learner – the solitary ...
(Date:7/12/2014)... to the new market research report "Security and Surveillance ... - Global Forecasts and Analysis to 2014 - 2020", ... estimated to be $6.08 billion in 2014 and are ... $8.61 billion by 2020. , Browse more than 93 ... pages and in-depth TOC on "Security and Surveillance Radar ...
(Date:7/12/2014)... The Passenger Information System market is estimated to grow ... 2019, at an expected CAGR of 26.5% for the ... infrastructure in North America is well developed and network ... of the region. The growing ridership figures in public ... are driving the North American Passenger Information System market ...
(Date:7/12/2014)... Dennis Thompson HealthDay Reporter ... no way to guarantee that a surgical technique used to ... won,t increase the risk of spreading cancer to other parts ... The advisory panel to the Food and Drug Administration also ... laparoscopic power morcellation -- should sign a written consent stating ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 The Security ... in 2013 to $3,376.6 million by 2019, at an ... and 2019. The challenges to counter the increasing number ... existence of outdated cyber defense systems in organizations are ... innovating and remodeling their existing architecture to develop better ...
Breaking Medicine News(10 mins):Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 3Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 4Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 4Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 4Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 2Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4
... Anniversary of Delivering Innovative Solutions to Improve the ... ATLANTA, June 10 Craneware, Inc., (AIM: CRW.L), ... the U.S. healthcare market, today announced that key ... presentations during the Healthcare Financial Management Association,s (HFMA,s) ...
... an increasing demand for massage therapy education in the Chicago ... the Prologis Business Park in Woodridge, Ill. Cortiva is ... , , Cortiva Institute offers a diploma in ... length (56 quarter credits) and includes hands-on courses in Practical ...
... Addresses Medical Research Compliance Requirements , , AUSTIN, ... of medical research management software for the Life Sciences ... product line, the Biosafety Solution. , , TOPAZ ... process, from protocol inception to approval, as required by ...
... EDISON, N.J., June 10 BellaDerm, the first human ... contouring procedures, is being introduced today by MTF, the ... , , BellaDerm is a unique acellular ... tissue has properties that are very appealing to plastic ...
... ALTOS, Calif., June 10 InteKrin Therapeutics Inc presented ... Association annual meeting in New Orleans demonstrating that once ... consistent with maximal dose thiazolidinedione (TZD) therapy but with ... The 4 week double blind placebo controlled study of ...
... RealAge and Co-Author of the YOU Book Series - Urges America to ... , , SAN DIEGO, June 10 A new survey released ... pressure are not at all familiar with the role of the renin ... about 9 out of 10 adults with high blood pressure (89%) both ...
Cached Medicine News:Health News:Craneware to Highlight Best Practices for Optimizing Revenue Capture Processes in Two Seminar Presentations during HFMA's 2009 ANI: The Healthcare Finance Conference 2Health News:Cortiva Institute to Open Branch Location in Woodridge, IL 2Health News:TOPAZ Technologies Introduces Biosafety Software Solution 2Health News:TOPAZ Technologies Introduces Biosafety Software Solution 3Health News:BellaDerm(TM), a Unique Human Skin Tissue Implant for Facial and Body Contouring, is Introduced by MTF 2Health News:InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting 2Health News:InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting 3Health News:New Survey Finds Majority of Adults Don't Understand a Key Source of High Blood Pressure 2Health News:New Survey Finds Majority of Adults Don't Understand a Key Source of High Blood Pressure 3Health News:New Survey Finds Majority of Adults Don't Understand a Key Source of High Blood Pressure 4Health News:New Survey Finds Majority of Adults Don't Understand a Key Source of High Blood Pressure 5Health News:New Survey Finds Majority of Adults Don't Understand a Key Source of High Blood Pressure 6
Triad Plus PVP-I Scrub Solution has broad-spectrum germicidal action.This special formula is designed to help break down body oils and yet limit the bubbles the surfactants allowing easy removal and ...
... Solution is the ... povidone-iodine. It is a ... kills gram-positive and gram-negative ... organisms), as well as ...
... allows the user to prep one uniform, ... less than 2-minutes. It also utilizes the ... scrubbing and healthcare personnel handwashing. ACTIPREP also ... a tacky surface for drapes to adhere ...
... Aplicare's disposable 1-ounce pouches are designed ... reducing waste. They are used in nursing ... emergency rooms and many other hospital departments. ... which is a mild antiseptic, germicidal and ...
Medicine Products: